Rwanda Biomedical Center, Kigali, RW.
University of Rwanda, College of Medicine and Health Sciences, Kigali, RW.
Ann Glob Health. 2020 Sep 9;86(1):115. doi: 10.5334/aogh.2719.
In many developing countries, rheumatic heart disease (RHD) is diagnosed at an advanced stage and requires surgery for patient survival. However, access to cardiac surgery in this context is limited and often provided through partnerships, requiring centralized patient data systems for monitoring and follow-up.
This study used data from a national postoperative RHD registry to analyze clinical outcomes of Rwandan patients who received surgery between 2006 and 2017.
The RHD registry was created in 2017 using data compiled from Rwanda Ministry of Health and RHD surgery partners. We extracted pre- and post-operative data on patients who were alive and in care. We excluded patients who died or were lost to follow-up, as their data was not collected in the registry. We evaluated the association between demographic, surgical, and follow-up characteristics and most recent patient symptoms, categorized by New York Heart Association (NYHA) class.
Among the 191 patients eligible for inclusion in this study, 107(56.0%) were female, 110(57.6%) were adults at the time of surgery (>15 years), and 128(67.4%) had surgery in Rwanda. Most patients (n = 166, 86.9%) were on penicillin prophylaxis. Of the patients with mechanical valves, 47(29.9%) had therapeutic International Normalized Ratio values. 90% of patients were asymptomatic (NYHA I) at the time of most recent visit. NYHA class was not significantly associated with any of the considered variables. The median length of follow-up for patients was four years (IQR: 2, 5 years).
This study shows both the feasibility and challenges of creating a RHD registry 11 years after the national initiation of RHD surgeries. Most patients captured in the registry are asymptomatic; however, collecting details on patients who had died or were lost to follow-up has proven difficult. Implementing strategies to maintain a complete and up-to-date registry will facilitate follow-up for pre- and postoperative patients.
在许多发展中国家,风湿性心脏病(RHD)在晚期才被诊断出来,需要手术才能挽救患者生命。然而,在这种情况下,获得心脏手术的机会有限,通常通过合作关系提供,这需要集中的患者数据系统进行监测和随访。
本研究使用来自全国性术后 RHD 登记处的数据,分析了 2006 年至 2017 年期间接受手术的卢旺达患者的临床结局。
RHD 登记处于 2017 年创建,使用卢旺达卫生部和 RHD 手术合作伙伴汇编的数据。我们提取了存活并在护理中的患者的术前和术后数据。我们排除了死亡或失访的患者,因为他们的数据未在登记处收集。我们评估了人口统计学、手术和随访特征与最近患者症状之间的关联,症状根据纽约心脏协会(NYHA)分类进行分类。
在这项研究中,有 191 名符合条件的患者,其中 107 名(56.0%)为女性,110 名(57.6%)在手术时为成年人(>15 岁),128 名(67.4%)在卢旺达接受手术。大多数患者(n=166,86.9%)接受青霉素预防治疗。在使用机械瓣膜的患者中,47 名(29.9%)的国际标准化比值(INR)值为治疗性。在最近一次就诊时,90%的患者无症状(NYHA I)。NYHA 类别与所考虑的任何变量均无显著关联。患者的中位随访时间为四年(IQR:2,5 年)。
这项研究表明,在全国性开展 RHD 手术 11 年后,建立 RHD 登记处既具有可行性,也面临挑战。在登记处中捕获的大多数患者无症状;然而,收集已经死亡或失访的患者的详细信息已被证明很困难。实施策略以保持完整和最新的登记处将有助于对术前和术后患者进行随访。